Earnings Alerts

Raymond James Financial (RJF) Earnings: 1Q Adjusted EPS Surpasses Expectations with Strong Revenue Growth

By January 30, 2025 No Comments
  • Raymond James reports an adjusted earnings per share (EPS) of $2.93 for the first quarter, outperforming the expected $2.68, and surpassing the previous year’s $2.40.
  • The company’s reported EPS is $2.86, an increase from last year’s $2.32.
  • The effective tax rate for the quarter is 19.9%, lower than last year’s 21%.
  • Net revenue for the quarter reaches $3.54 billion, a 17% increase year-over-year, exceeding the forecast of $3.48 billion.
  • Analyst recommendations for Raymond James include 8 buys, 10 holds, and 1 sell.

A look at Raymond James Financial Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth4
Resilience5
Momentum5
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Raymond James Financial, a well-established financial services provider operating in multiple countries, seems to have a promising long-term outlook based on the Smartkarma Smart Scores. With a strong score of 4 for Growth and top-notch Resilience and Momentum scores of 5 each, the company is anticipated to continue expanding and adapting well to market changes. This indicates a positive trajectory for Raymond James Financial‘s business development and ability to seize growth opportunities.

Although the company received slightly lower scores in Value and Dividend, with 3 and 2 respectively, its impressive growth potential, resilience, and momentum bode well for its future success. Investors may find Raymond James Financial an attractive prospect for long-term investment based on its solid performance across critical factors essential for sustained growth and profitability.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars